Tanaka Capital Management Inc Corcept Therapeutics Inc Transaction History

Tanaka Capital Management Inc

$42 Million
Q1 2025

A detailed history of Tanaka Capital Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tanaka Capital Management Inc holds 93,184 shares of CORT stock, worth $8.24 Million. This represents 25.34% of its overall portfolio holdings.

Number of Shares

93,184

Previous 111,551 16.47%

Holding current value

$8.24 Million

Previous $5.62 Million 89.34%

% of portfolio

25.34%

Previous 12.85%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$49.85 - $114.22 $915,594 - $2.1 Million	-18,367 Reduced 16.47%	93,184 $10.6 Million
Q4 2024 Feb 14, 2025	SELL	$44.66 - $60.85 $26,126 - $35,597	-585 Reduced 0.52%	111,551 $5.62 Million
Q3 2024 Nov 15, 2024	BUY	$29.51 - $46.26 $349,988 - $548,643	11,860 Added 11.83%	112,136 $5.19 Million
Q2 2024 Aug 15, 2024	BUY	$22.21 - $34.48 $208,774 - $324,111	9,400 Added 10.34%	100,276 $3.26 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $1.13 Million - $1.48 Million	53,785 Added 145.01%	90,876 $2.29 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $11,863 - $15,716	-478 Reduced 1.27%	37,091 $1.21 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $44,599 - $68,614	2,030 Added 5.71%	37,569 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $64,987 - $94,875	-3,750 Reduced 9.54%	35,539 $845,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $3,801 - $5,798	-230 Reduced 0.58%	39,289 $885,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $8,977 - $12,253	-525 Reduced 1.31%	39,519 $782,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $2,583 - $3,361	-110 Reduced 0.27%	40,044 $953,000
Q4 2020 Feb 11, 2021	SELL	$16.78 - $27.3 $2,684 - $4,368	-160 Reduced 0.4%	40,154 $1.05 Million
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $268,388 - $430,369	-21,540 Reduced 34.82%	40,314 $702,000
Q2 2020 Aug 17, 2020	SELL	$11.0 - $18.26 $41,305 - $68,566	-3,755 Reduced 5.72%	61,854 $1.04 Million
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $40,844 - $56,721	-4,040 Reduced 5.8%	65,609 $780,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $54,149 - $76,150	-4,490 Reduced 6.06%	69,649 $843,000
Q3 2019 Nov 15, 2019	SELL	$10.41 - $14.66 $27,950 - $39,362	-2,685 Reduced 3.5%	74,139 $1.05 Million
Q2 2019 Aug 15, 2019	SELL	$9.78 - $12.76 $26,895 - $35,090	-2,750 Reduced 3.46%	76,824 $857,000
Q1 2019 May 16, 2019	SELL	$10.03 - $15.71 $84,552 - $132,435	-8,430 Reduced 9.58%	79,574 $934,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $1,693 - $2,578	-150 Reduced 0.17%	88,004 $1.18 Million
Q2 2018 Aug 16, 2018	SELL	$15.3 - $19.69 $863,654 - $1.11 Million	-56,448 Reduced 39.04%	88,154 $1.39 Million
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $63,028 - $110,160	4,320 Added 3.08%	144,602 $2.38 Million
Q4 2017 Feb 16, 2018	BUY	$15.77 - $20.72 $6,544 - $8,598	415 Added 0.3%	140,282 $2.53 Million
Q3 2017 Nov 16, 2017	BUY	$12.3 - $19.3 $1.72 Million - $2.7 Million	139,867	139,867 $2.7 Million

Others Institutions Holding CORT

# of Institutions

468

Shares Held

82.8M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $9.47B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanaka Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tanaka Capital Management Inc with notifications on news.

Account

Tanaka Capital Management Inc Corcept Therapeutics Inc Transaction History